Sunday
2:00 pm - 9:00 pm
Arrival and Check-in
6:00 pm - 7:00 pm
Dinner
7:30 pm - 7:40 pm
Introductory Comments by GRC Staff / Welcome and Introduction from the Chairs
7:40 pm - 9:30 pm
Keynote Session: The Realities of Tuberculosis Treatment for the Patients
7:40 pm - 7:45 pm
Introduction by Discussion Leader
7:45 pm - 8:05 pm
Late-Breaking Topic
8:05 pm - 8:10 pm
Discussion
8:10 pm - 8:40 pm
"Paediatric Tuberculosis Disease Pathogenesis Offers Unique Therapeutic Opportunities"
8:40 pm - 8:50 pm
Discussion
8:50 pm - 9:20 pm
"Establishing Community Peer-Led Monitoring Systems for TB Projects-Lessons Learned from Ubumi Bwandi Project in an Urban Community in Zambia"
9:20 pm - 9:30 pm
Discussion
Monday
7:30 am - 8:30 am
Breakfast
9:00 am - 12:30 pm
Tools and Models for Drug Development, Discovery, and Analysis of Resistance
9:00 am - 9:05 am
Introduction by Discussion Leader
9:05 am - 9:30 am
"Granulomas and Tuberculosis Therapy"
9:30 am - 9:40 am
Discussion
9:40 am - 10:05 am
"Disrupting Cord Architectures as Host-Directed Therapy in Mycobacterium Tuberculosis Infections"
10:05 am - 10:15 am
Discussion
10:15 am - 10:40 am
Coffee Break
10:40 am - 11:05 am
"Advanced In Vitro Tools to Inform Progression of Novel TB Drug Regimens"
11:05 am - 11:15 am
Discussion
11:15 am - 11:40 am
"AI-Enabled Anti-TB Hit ID and LO"
11:40 am - 11:50 am
Discussion
11:50 am - 12:15 pm
"Phage Therapy for Tuberculosis - Tough Challenges and Unique Opportunities"
12:15 pm - 12:25 pm
Discussion
12:25 pm - 12:30 pm
General Discussion
12:30 pm - 1:30 pm
Lunch
1:30 pm - 4:30 pm
Free Time
4:30 pm - 6:00 pm
Poster Session
6:00 pm - 8:00 pm
Approaches to Seeking New Chemical Matter
6:00 pm - 6:05 pm
Introduction by Discussion Leader
6:05 pm - 6:30 pm
"New Strategies for Tuberculosis Therapy"
6:30 pm - 6:40 pm
Discussion
6:40 pm - 7:05 pm
"Logical Luck: Mixing Methods for Modern Small Molecule Discovery"
7:05 pm - 7:15 pm
Discussion
7:15 pm - 7:40 pm
"DDU384, the Journey from Phenotypic Hit Towards Preclinical Selection"
7:40 pm - 7:50 pm
Discussion
7:50 pm - 8:00 pm
General Discussion
8:00 pm - 9:00 pm
Dinner
Tuesday
7:30 am - 8:30 am
Breakfast
8:30 am - 9:00 am
Group Photo
9:00 am - 12:30 pm
Improving TB Chemotherapy, Including Through Translational Science and Clinical Trial Design
9:00 am - 9:05 am
Introduction by Discussion Leader
9:05 am - 9:30 am
"Lesion-Centric PK and PD Considerations for TB Drug Discovery and Regimen Design"
9:30 am - 9:40 am
Discussion
9:40 am - 10:05 am
"Personalized CD8 T-Cell Immunity: Computational Approaches to Profile Patient-Specific Responses Against Tuberculosis"
10:05 am - 10:15 am
Discussion
10:15 am - 10:45 am
Coffee Break
10:45 am - 11:10 am
"Early Bactericidal Activity, Safety and PK of the New Alpibectir-Ethionamide Combination (AlpE) for the Treatment of TB"
11:10 am - 11:20 am
Discussion
11:20 am - 11:30 am
Short Talk Selected from Poster Abstracts
11:30 am - 11:35 am
Discussion
11:35 am - 11:45 am
Short Talk Selected from Poster Abstracts
11:45 am - 11:50 am
Discussion
11:50 am - 12:00 pm
Short Talk Selected from Poster Abstracts
12:00 pm - 12:05 pm
Discussion
12:05 pm - 12:15 pm
Short Talk Selected from Poster Abstracts
12:15 pm - 12:20 pm
Discussion
12:20 pm - 12:30 pm
General Discussion
12:30 pm - 1:30 pm
Lunch
1:30 pm - 4:30 pm
Free Time
4:30 pm - 6:00 pm
Poster Session
6:00 pm - 8:00 pm
Partnering Diagnostic Approaches with the Development and Implementation of Therapeutic Strategies
6:00 pm - 6:05 pm
Introduction by Discussion Leader
6:05 pm - 6:30 pm
"Implementing New Therapeutic Strategies for Tuberculosis"
6:30 pm - 6:40 pm
Discussion
6:40 pm - 7:05 pm
"From New Insights into Pathogenesis to Host-Directed Diagnosis and Treatment for TB Meningitis in Clinical Cohorts"
7:05 pm - 7:15 pm
Discussion
7:15 pm - 7:40 pm
"How to Improve the Alignment Between New Drugs and Diagnostics for the Treatment of Tuberculosis"
7:40 pm - 7:50 pm
Discussion
7:50 pm - 8:00 pm
General Discussion
8:00 pm - 9:00 pm
Dinner
Wednesday
7:30 am - 8:30 am
Breakfast
9:00 am - 12:30 pm
Finding and Optimizing Lead Compounds and Strategies to Treat Tuberculosis
9:00 am - 9:05 am
Introduction by Discussion Leader
9:05 am - 9:30 am
"New Therapeutic Approaches for Tuberculosis"
9:30 am - 9:40 am
Discussion
9:40 am - 10:05 am
"Recent Efforts in the Translation of Mycobacterium Tuberculosis KasA Inhibitors"
10:05 am - 10:15 am
Discussion
10:15 am - 10:45 am
Coffee Break
10:45 am - 11:10 am
"Development of a Novel Liposomal Oxazolidinone as a Long Acting Injectable for the Treatment of Multidrug-Resistant Tuberculosis"
11:10 am - 11:20 am
Discussion
11:20 am - 11:30 am
Short Talk Selected from Poster Abstracts
11:30 am - 11:35 am
Discussion
11:35 am - 11:45 am
Short Talk Selected from Poster Abstracts
11:45 am - 11:50 am
Discussion
11:50 am - 12:00 pm
Short Talk Selected from Poster Abstracts
12:00 pm - 12:05 pm
Discussion
12:05 pm - 12:15 pm
Short Talk Selected from Poster Abstracts
12:15 pm - 12:20 pm
Discussion
12:20 pm - 12:30 pm
General Discussion
12:30 pm - 1:30 pm
Lunch
1:30 pm - 4:30 pm
Free Time
4:30 pm - 6:00 pm
Poster Session
6:00 pm - 8:00 pm
Structural, Computational, and Chemical Genetic Approaches to Identify Ways to Treat Tuberculosis
6:00 pm - 6:05 pm
Introduction by Discussion Leader
6:05 pm - 6:30 pm
"Targeting the Terminal Respiratory Oxidases: Pretomanid, Telacebec, and Emerging Synergistic Strategies for Tuberculosis"
6:30 pm - 6:40 pm
Discussion
6:40 pm - 7:05 pm
"Targeting Transcription in Mycobacterium Tuberculosis: A Strategic Approach to Develop Synergistic Treatments"
7:05 pm - 7:15 pm
Discussion
7:15 pm - 7:25 pm
Short Talk Selected from Poster Abstracts
7:25 pm - 7:30 pm
Discussion
7:30 pm - 7:40 pm
Short Talk Selected from Poster Abstracts
7:40 pm - 7:45 pm
Discussion
7:45 pm - 7:55 pm
Short Talk Selected from Poster Abstracts
7:55 pm - 8:00 pm
Discussion
8:00 pm - 9:00 pm
Dinner
Thursday
7:30 am - 8:30 am
Breakfast
8:30 am - 9:00 am
Business Meeting
Nominations for the Next Vice Chair(s); Complete the GRC Evaluation Forms; Election of the Next Vice Chair(s)
9:00 am - 12:30 pm
Leveraging the Host to Fight Tuberculosis
9:00 am - 9:05 am
Introduction by Discussion Leader
9:05 am - 9:30 am
"Bioenergetic Crosstalk Between Host and Pathogen Mediates Drug Tolerance in Mycobacterium Tuberculosis "
9:30 am - 9:40 am
Discussion
9:40 am - 10:05 am
"Host-Directed Therapy to Enhance Treatment Shortening"
10:05 am - 10:15 am
Discussion
10:15 am - 10:40 am
Coffee Break
10:40 am - 11:05 am
"Targeting Lipid Droplets to Achieve Host Mediated Control of TB Infection"
11:05 am - 11:15 am
Discussion
11:15 am - 11:40 am
"Randomly Barcoded Transposon Sequencing Reveals Novel Determinants of M. Tuberculosis Strategies for Nutrient Acquisition and Resistance to Stress"
11:40 am - 11:50 am
Discussion
11:50 am - 12:15 pm
"CRISPR/Cas9 Editing of Primary Human Macrophages to Define Targets for Host-Directed Therapy for TB"
12:15 pm - 12:25 pm
Discussion
12:25 pm - 12:30 pm
General Discussion
12:30 pm - 1:30 pm
Lunch
1:30 pm - 4:30 pm
Free Time
4:30 pm - 6:00 pm
Poster Session
6:00 pm - 8:00 pm
Advancing our Understanding of Mycobacterium Tuberculosis to Improve Tuberculosis Chemotherapy
6:00 pm - 6:05 pm
Introduction by Discussion Leader
6:05 pm - 6:30 pm
"Probing Mycobacterial Cell Envelope Perturbations"
6:30 pm - 6:40 pm
Discussion
6:40 pm - 7:05 pm
7:05 pm - 7:15 pm
Discussion
7:15 pm - 7:40 pm
"Differentially Culturable Bacteria in Tuberculosis Treatment, Relapse, and Transmission: Challenging a Century of Dogma"
7:40 pm - 7:50 pm
Discussion
7:50 pm - 8:00 pm
General Discussion
8:00 pm - 9:00 pm
Dinner
Friday
7:30 am - 8:30 am
Breakfast
9:00 am
Departure